PART I Overview Nexalin is headquartered, and maintains its base of management and operations, in Houston, Texas. We design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. We developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety, insomnia and depression without the need for drugs or psychotherapy. Our original Gen-1 devi...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001829126-26-002673 | EDGAR | 68K words |
| 2025-03-14 | 2024-12-31 | 0001829126-25-001794 | EDGAR | — |
| 2024-03-27 | 2023-12-31 | 0001829126-24-001935 | EDGAR | — |
| 2023-03-27 | 2022-12-31 | 0001829126-23-002259 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001829126-25-009159 | EDGAR | 22K words |
| 2025-08-06 | 2025-06-30 | 0001829126-25-005851 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001829126-25-003612 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001829126-24-007369 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001829126-24-005306 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001829126-24-003241 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001829126-23-007325 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001829126-23-005281 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001829126-23-003245 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001829126-22-019147 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-25 | 0001829126-26-001634 | EDGAR | 1K words |
| 2026-01-23 | 0001829126-26-000513 | EDGAR | — |
| 2025-12-05 | 0001829126-25-009755 | EDGAR | — |
| 2025-10-15 | 0001829126-25-008140 | EDGAR | — |
| 2025-09-22 | 0001829126-25-007572 | EDGAR | — |
| 2025-08-04 | 0001829126-25-005715 | EDGAR | — |
| 2025-07-21 | 0001829126-25-005224 | EDGAR | — |
| 2025-07-17 | 0001829126-25-005112 | EDGAR | — |
| 2025-06-09 | 0001829126-25-004343 | EDGAR | — |
| 2025-05-06 | 0001829126-25-003427 | EDGAR | — |
75 total filings indexed. 51 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001527352 |
| Ticker | NXL |
| Exchange | Nasdaq |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | DE |
| Website | https://www.nexalin.com |
| Listed | 2022-09-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report